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Objectives. This study sought to investigate the relative and 
incremental prognostic value of demographic, historical, clinical, 
echocardiographic and mitral Doppler variables in patients with 
left ventricular systolic dysfunction. 
Background. The prognostic value of diastolic abnormalities a  
assessed by mitral Doppler echocardiography as yet to be 
defined. 
Metiwd. A total of 508 patients with left ventricular ejection 
fraction <35% were followed up for a mean (+SD) period of 29 -+ 
11 months. 
Results. During the follow-up period, 148 patients (29.1%) were 
admitted to the hospital for congestive heart failure, and 100 
patients (19.7%) died. By Cox model analysis, Doppler-derived 
mitral deceleration time of early filling <125 ms (relative risk 
[RR] 1.93, 95% confidence interval [CI] 1.4 to 3.7), New York 
Heart Association functional class HI or IV (RR 1.49, 95% CI 1.4 
to 2.3), ejection fraction <25% (RR 1.85, 95% CI 1.6 to 2.9), third 
heart sound (RR 2.06, 95% CI 1.8 to 3.2), age >60 years (RR 1.95, 
95% CI 1.8 to 3.1) and left atrial area >18 cm 2 (RR 1.73, 95% CI 
1.6 to 2.7) were all found to be independent and additional 
predictors of all-cause mortality, and deceleration time was the 
single best predictor (chi-square 37.80). When all these significant 
variables were analyzed in hierarchic order, after age, functional 
class, third sound, ejection fraction and left atrial area, deceler- 
ation time still added significant prognostic information (global 
chi-square from 9.2 to 104.7). Also, deceleration time was the 
strongest independent predictor of hospital admission for conges- 
tive heart failure (RR 4.88, 95% CI 3.7 to 6.9) and cumulative 
events (congestive heart failure or all-cause mortality, or both; RR 
2.44, 95% CI 2.0 to 3.8) in both symptomatic and asymptomatic 
patients. 
Conclusions. Deceleration time of early filling is a powerful 
independent predictor of poor prognosis in patients with left 
ventricular systolic dysfunction, whether symptomatic or asymp- 
tomatic. A short (<125 ms) deceleration time by mitrai Doppler 
echocardiography adds important prognostic information com- 
pared with other clinical, functional and echocardiographic vari- 
ables. 
(J Am Coil Cardio11996;28:383-90) 
During the past decade, several indicators have been estab- 
lished to predict poor prognosis in patients with left ventricular 
dysfunction and chronic heart failure, including age, etiology, 
left ventricular ejection fraction, functional class, exercise 
capacity, pulmonary arterial pressures and cardiac output 
(1-4). It has also been demonstrated that left ventricular 
diastolic dysfunction may contribute to signs and symptoms of 
several cardiovascular disorders, particularly during periods of 
clinical deterioration (5). 
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Doppler echocardiography as provided a rapid, repeat- 
able, noninvasive method of assessing left ventricular filling in 
various cardiac diseases in which diastolic abnormalities have 
been observed, both with and without systolic dysfunction 
(6-9). Recently, the pathophysiology and clinical importance 
of the transmitral f ow velocity pattern as assessed by Doppler 
echocardiography have been extensively investigated (6-16). It 
has been observed that the so-called restrictive transmitral flow 
pattern, characterized by a shortened isovolumic relaxation 
time and deceleration time of early filling, minimal filling 
during atrial systole and increased ratio of peak flow velocity in 
early to late diastole, is a common finding in more symptomatic 
patients with elevated filling pressure and may be related to 
advanced New York Heart Association functional class and 
poor exercise capacity (%11,14-16). More recent studies have 
also indicated that Doppler-derived diastolic filling variables, 
specifically the restrictive filling pattern, may play an important 
role in predicting cardiac mortality in patients with cardiac 
amyloidosis (17), dilated cardiomyopathy (18-20) and conges- 
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tive heart failure (21). However, there are some limitations 
concerning the available prognostic studies with mitral Dopp- 
ler echocardiography that have so far blunted the clinical 
impact of these findings, for instance, the relatively small 
sample size of published studies and the highly selected nature 
of the patient populations. To date, a large-scale study based 
on a sample size sufficient o enable a conclusive definition of 
the prognostic value of diastolic abnormalities as assessed by 
Doppler echocardiography as not been performed. Further- 
more, the incremental prognostic value of abnormal filling 
patterns has never been investigated. 
Accordingly, the present study was designed to evaluate the 
capability of mitral Doppler echocardiography in the prognos- 
tic stratification of either symptomatic or asymptomatic pa- 
tients with left ventricular systolic dysfunction. The relative 
and incremental prognostic value of demographic, historic, 
clinical, echocardiographic and mitral Doppler variables was 
also assessed. 
Methods 
Subjects. Study patients were consecutively enrolled from 
the Heart Failure Unit at the Cardiology Department of 
Veruno Medical Center between January 1989 and March 
1993. Patients with either symptomatic or asymptomatic left 
ventricular systolic dysfunction as defined by resting echocar- 
diographic ejection fraction -<35% were eligible for the study. 
Patients were ineligible ff they were >80 years old or had any 
of the following: atrial fibrillation, echocardiographic images 
and mitral Doppler tracings of insufficient quality for analysis, 
hemodynamically serious valvular disease requiring operation, 
echocardiographic findings indicative of restrictive cardiomy- 
opathy, unstable angina pectoris, angina or myocardial isch- 
emia thought o be severe nough to require revascularization 
procedures, myocardial infarction during the previous 3 
months, severe pulmonary disease, coronary artery bypass 
surgery during the previous 6months, significant chronic renal 
failure (serum creatinine level >2 mg/dl), cancer or other 
systemic disease that might substantially shorten survival. 
Five hundred eight patients met the entry criteria for the 
study. All patients provided written informed consent to 
perform the protocol and to participate in this prospective 
study, which had been approved by the Science and Ethics 
Committee of our institution. 
Study protocol. The study consisted of two parts: noninva- 
sive evaluation at entry and follow-up. Entry evaluation in- 
cluded historic data collection, physical examination, func- 
tional classification and Doppler echocardiography. Patients' 
symptoms were assessed according to functional classification. 
Asymptomatic patients were assigned to functional class 2, 
mildly symptomatic patients to class II, those moderately 
symptomatic to class III and those very symptomatic with 
minimal activity or at rest to class IV. 
Eehocardiography. Complete M-mode and two-dimensional 
echocardiography and Doppler ultrasound examination were 
performed in all patients at the time of the entry visit in the 
standard manner using commercially available equipment 
(Hewlett-Packard imaging system, model 77729-A or 77622- 
A). Diastolic flow velocity at the left ventricular inflow tract 
was recorded with pulsed wave Doppler echocardiography 
using a 2.5-MHz transducer, as previously described (9,15). In 
the apical four-chamber view, the Doppler sample volume was 
placed in the middle of the left ventricular inflow tract, -1 cm 
below the plane of the mitral annulus between the tips of the 
mitral leaflets, where maximal flow velocity in early diastole 
was recorded. Care was taken to obtain the smallest possible 
angle between the presumed irection of the diastolic blood 
flow and the orientation of the ultrasound beam. Color Dopp- 
ler measurements were also performed in all patients to assess 
the degree of both mitral and tricuspid regurgitation. Images 
were stored on a professional videotape (Panasonic AG- 
7330E) for further analysis. 
Measurements, Left ventricular volume was calculated 
from orthogonal apical views of the two-dimensional echocar- 
diograrn using the biplane area-length method (10). Ejection 
fraction was derived from the standard equation. Maximal 
atrial area and right ventricular end-diastolic diameter 1 cm 
below the tricuspid annulus were also measured from the 
apical four-chamber view. For the mitral Doppler echocardio- 
graphic variables, traces of five to eight consecutive cardiac 
cycles were analyzed using a microcomputer-based digitizing 
system (Leading Edge), and the following variables were 
measured: peak flow velocity in early diastole (E), peak flow 
velocity at atrial contraction (A), peak E/A wave velocity ratio 
and deceleration time of early filling. To avoid the influence of 
heart rate, deceleration time was calculated as the time 
between peak E wave and the upper deceleration slope 
extrapolated to the zero baseline (10,15). Cardiac cycles with 
nonlinear deceleration slopes and fusion of early and late 
mitral flow velocity were excluded from the analysis. The 
restrictive filling pattern was defined as an E/A ratio >-2 or by 
the combination of an E/A ratio between 1 and 2 with a 
deceleration time -<140 ms. The nonrestrictive pattern was 
defined as E/A ratio -< 1 or E/A ratio between 1 and 2 with 
deceleration time >140 ms (21). Mitral and tricuspid regurgi- 
tation were evaluated by color Doppler flow imaging and 
graded as none, mild, moderate or severe, according to previ- 
ously reported criteria (22). 
Follow-up data. After entry evaluation, patients were seen 
in our outpatient clinic at regular intervals (every 6 months). 
The follow-up of patients who did not attend the scheduled 
appointments was obtained by personal communication with 
the patient's physician and review of the patient's chart, 
telephone interview with the patient conducted by trained 
personnel or review of the patient's hospital record. Follow-up 
data were obtained in all patients. The outcome vents were 
all-cause mortality (death from all causes), hospitalization for 
congestive heart failure and total events (death or hospitaliza- 
tion for congestive heart failure). Only one event was consid- 
ered in each patient, and any event occurring after the initial 
event was not considered. 
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Statistical analysis. Kaplan-Meier life table estimates of 
survival, hospital admission for congestive heart failure-free 
survival and of all-event-free survival were used to summarize 
the follow-up experience in these patients and to clarify 
presentation. The individual effect of certain variables on 
event-free survival was evaluated with the use of the Cox 
regression model (BMDP2L, Department of Biomathematics, 
University of California at Los Angeles, revised 1987). All 
variables analyzed in this study were first assessed by univariate 
analysis. Differences between patients with events and event- 
free survivors were also compared by unpaired t testing and 
frequency of parameters and events by the chi-square test with 
Yates correction. Those variables that showed a significant 
association with the outcome (p < 0.1) were included in the 
multivariate Cox model in stepwise fashion. 
Two different multivariate analyses were carried out with 
the Cox proportional hazards model procedure. The first 
analysis was performed according to the unmodified forward 
selection stepwise procedure. In this analysis, variables were 
entered into or removed from the model on the basis of a 
computed significance probability (maximized partial likeli- 
hood ratio). The p values to enter and remove variables were 
0.1 and 0.15, respectively. In order to clarify the incremental 
information from the addition of the historic, clinical, echo- 
cardiographic and mitral-Doppler variables, we also analyzed 
the data according to a modified stepwise procedure in which 
the significant individual factors were included in the model 
in the same order in which they are actually considered in 
clinical practice (demographic or historic data first, clinical 
data second, echocardiographic variables third and mitral- 
Doppler variables last). Increment in information of the model 
at each step was considered significant when the difference in 
log-likelihood associated with each model (adjusted for differ- 
ences in degrees of freedom) corresponded to p < 0.05. 
The demographic and historic variables elected for exam- 
ination were age (continuous values), gender, etiology of 
idiopathic dilated cardiomyopathy, history of previous myocar- 
dial infarction, previous coronary artery bypass surgery and 
overt heart failure (yes/no for all). Clinical variables included 
functional class (I to IV) and presence of third heart sound and 
pulmonary rales (yes/no) on physical examination. For the 
echocardiographic data, the variables elected were left ven- 
tricular volumes and ejection fraction, right ventricular end- 
diastolic dimension, right and left atrial area (continuous 
values for all), and both mitral and tricuspid regurgitation 
(graded as absent, mild, moderate or severe). Finally, the 
mitral Doppler variables elected were peak E and peak A 
velocity, E/A ratio, deceleration time of early filling (continu- 
ous values for all) and the presence of a restrictive filling 
pattern (yes/no). A p value <0.05 was considered statistically 
significant. 
Resul ts  
The study group consisted of 508 consecutive patients (451 
men, 57 women; mean age 59 _+ 10 years). The etiology of left 
ventricular dysfunction in these patients was coronary artery 
disease (history of previous myocardial infarction or coronary 
artery bypass urgery) in 94% and idiopathic dilated cardio- 
myopathy in the remaining 6%. Patients were taking a variety 
of medications including digitalis (197 patients), diuretic 
agents (308 patients), angiotensin-converting enzyme inhibi- 
tors (303 patients) and nitrates (388 patients). At entry, 137 
patients had symptomatic left ventricular dysfunction as de- 
fined by a previous unequivocal episode of clinical heart 
failure, and 107 patients were in functional class III or IV. 
Mean left ventricular ejection fraction was 26 _+ 5% (10% to 
35%). 
Prognostic data. Patients were followed up for a period of 
29 - 11 months (range 6 to 58). During the follow-up period, 
148 patients (29.1%) were admitted to the hospital for conges- 
tive heart failure, and 100 patients (19.7%) died. In more 
detail, there were 87 (17.1%) cardiac and 13 (2.6%) non- 
cardiac-related deaths. Of the 87 patients with cardiac deaths, 
48 died of refractory congestive heart failure, 24 of sudden 
death and 15 of fatal myocardial infarction. The 1-year and 
4-year cumulative mortality rates were 13% and 28%, respec- 
tively. Overall, there were 190 (37%) hard events (all-cause 
mortality or hospitalization for congestive heart failure). 
At univariate analysis, except for gender and etiology, all 
baseline clinical features and all echocardiographic (including 
left ventricular volumes and ejection fraction, atrial size, right 
ventricular dimension and regurgitations) and mitral Doppler 
variables were found to be predictive of fatal outcome. Clini- 
cal, echocardiographic and mitral Doppler data in survivors 
and nonsurvivors are summarized in Table 1. Nonsurvivors 
were significantly older, in a higher functional class and more 
frequently had a history of clinical heart failure or showed 
third heart sound and pulmonary tales on physical examina- 
tion. Nonsurvivors also had larger left ventricular volumes and 
larger left and right atrial size, a larger right ventricle, more 
depressed left ventricular systolic function, and they more 
frequently showed significant mitral and tricuspid regurgita- 
tion. In addition, analysis of mitral Doppler curves revealed in 
nonsurvivors (compared with survivors) a significantly higher 
peak E velocity, lower peak A velocity, higher E/A ratio and a 
shorter deceleration time of early filling. Digitalis and diuretic 
drugs were more frequently administered in nonsurvivors, but 
patients who received angiotensin-converting enzyme inhibi- 
tors and nitrates were equally distributed in the two groups. 
However, when multivariate analysis in a forward stepwise 
regression procedure was performed (including in the model 
all significant baseline clinical characteristics, echocardio- 
graphic and mitral Doppler variables, and the use of digitalis, 
diuretics, angiotensin-converting e zyme inhibitors and other 
vasodilators), only deceleration time -< 125 ms, functional class 
1II or IV, ejection fraction -<25%, presence of third heart 
sound, age >60 years and left atrial area >18 cm 2 emerged as 
independent and additional predictors of subsequent death 
(Table 2). Deceleration time proved the single best predictor 
(chi-square 37.80). When these six significant variables were 
entered into the model in hierarchic order according to a 
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Table 1. Baseline Clinical Echocardiographic and Mitral-Doppler 
Characteristics of Survivors and Nonsurvivors 
All Patients Survivors Nonsurvivors 
(n = 508) (n = 408) (n = 100) p Value 
Clinical data 
Age (yr) 59 _+ 9 57 _+ 8 61 +_ 9 0.0040 
Overt CHF 137 (27%) 86 (21%) 51 (51%) 0.0000 
NYHA III or IV 107 (81%) 63 (15%) 44 (44%) 0.0000 
Third heart sound 59 (12%) 31 (7.5%) 28 (28%) 0.0000 
Pulmonary tales 57 (11%) 31 (7.5%) 26 (26%) 0.0000 
Echocardiographic data 
LVEDVI (ml/m z) 106 _+ 32 101 + 25 124 _+ 46 0.0000 
LVESVI (ml/m 2) 77 _+ 29 72 _+ 23 96 _+ 42 0.0000 
LVEF (%) 26 -+ 5 28 _+ 5 23 + 6 0.0009 
Left atrial area  (cm 2) 17 -+ 5 16 ± 4 19 _+ 6 0.0002 
Right atrial area (cm 2) 13 _+ 4 12 ± 3 14 _+ 4 0.0002 
RVEDD (ram) 29 _+ 5.6 28 _+ 5.4 31 ± 6.2 0.0001 
MR mild-severe 143 (28%) 90 (22%) 53 (53%) 0.0000 
TR mild--severe 33 (6%) 14 (3%) 19 (19%) 0.0000 
Mitral Doppler data 
Peak E velocity (cnfs) 67 ± 25 64 _+ 24 78 _+ 26 0.0000 
Peak A velocity (cm/s) 56 -+ 24 59 _+ 23 46 ± 25 0.0000 
E/A ratio 1.64 _+ 1.42 1.43 _+ 1.2 2.5 _+ 1.9 0.0000 
Dec time (ms) 144 + 43 151 _+ 42 119 _+ 41 0.0000 
Restrictive filling 211 (42%) 143 (35%) 68 (68%) 0.0000 
pattern 
Medication 
Digitalis 197 (39%) 139 (34%) 58 (58%) 0.0000 
Diuretic drugs 308 (61%) 233 (57%) 75 (75%) 0.0010 
ACE inhibitors 303 (60%) 244 (60%) 59 (59%) NS 
Nitrates 388 (76%) 313 (77%) 75 (75%) NS 
Data presented are mean value ± SD or number (%) of patients. A = atrial 
contraction; ACE = angiotensin-converting enzyme; CHF = congestive heart 
failure; Dec time = deceleration time of early filling; E = early diastole; 
LVEDVI = left ventricular end-diastolic volume index; LVEF = left ventricular 
ejection fraction; LVESVI = left ventricular end-systolic volume index; MR = 
mitral regurgitation; NYHA - New York Heart Association functional class; 
RVEDD = right ventricular end-diastolic diameter; TR = tricuspid regurgita- 
tion. 
realistic interactive clinical approach, after considering age 
(demographic data, step 1), functional class and third heart 
sound (clinical data, step 2), left ventricular ejection fraction 
and left atrial area (echocardiographic data, step 3), it was 
found that deceleration time (step 4) still added significant 
prognostic information. Global chi-square value, as an index of 
the predictive power of the significant variables that emerged 
from the four major categories, improved from 9.2 to 104.7 
(Table 3). Survival according to the deceleration time is 
reported in the curves in Figure 1A. The cumulative 4-year 
mortality rate was 45% in patients with a deceleration time 
-<125 ms and 13% in those with a deceleration time >125 ms 
(p < 0.0001). Mean deceleration time in patients who died 
secondary to refractory heart failure was significantly (p < 
0.001) shorter (98 _+ 29 ms) than that in patients who had a 
sudden death (121 _+ 36 ms) or a fatal myocardial infarction 
(167 +_ 39 ms). Similarly, the proportion of patients with a 
short (-<125 ms) deceleration time was significantly (p < 
0.001) higher among those who died of refractory heart failure 
Table 2. Ranked Independent Predictors of All-Cause Mortality in 
Study Cohort by Cox Model According to Forward 
Stepwise Procedure 
Variable Chi-Square p Value Relative Risk 95% CI 
Dec time -<125 ms 37.80 0.000 1.93 1.4-3.7 
NYHA III or IV 19.54 0,000 1.49 1.4-2.3 
LVEF -<25% 10.20 0.001 1.85 1.6-2.9 
3rd heart sound 8.20 0.004 2.06 1.8-3.2 
Age >60 yr 6.10 0.014 1.95 1.8-3.1 
Left atrial area >18 cm 2 5.79 0.016 1.73 1.6-2.7 
Each ehi-square and p value is a measure of the improvement that each 
selected variable makes in a model containing all other significant variables. The 
relative risk is the independent risk of a cardiac event hat is associated with a 
variable. The total risk is the product of the risks associated with each variable 
when present. CI = confidence interval; other abbreviations as in Table 1. 
(91%) than in those with sudden death (65%) or fatal myo- 
cardial infarction (14%). Of note, patients who died of con- 
gestive heart failure and those who died suddenly had a similar 
ejection fraction (23 _+ 7% and 25 -+ 6%, respectively), which 
was lower than that observed in patients who died from 
myocardial infarction (28 +_ 7%), though the difference was 
statistically significant (p < 0.05) only with the heart failure 
group. 
Furthermore, when survival without hospital admission for 
congestive heart failure and survival without any events (hos- 
pital admission for heart failure or all-cause mortality, or both) 
were analyzed, deceleration time emerged as the most power- 
ful independent predictor of adverse outcome (Tables 4 and 
5). Again, when the incremental prognostic value of the 
significant variables was assessed in hierarchic order, deceler- 
ation time added prognostic information after demographic, 
clinical and echocardiographic data. The addition of clinical 
(functional class and pulmonary rales) and historic (overt heart 
failure) data to age improved the global chi-square value from 
9.2 to 125.5; the addition of echocardiographic data (left 
ventricular end-systolic volume, ejection fraction and left atrial 
area) to age and clinical data improved the value to 174.1. 
Finally, the addition of mitral deceleration time to demo- 
Table 3. Significant Predictors of Death According to an Interactive 
Stepwise Procedure: Incremental Prognostic Value of Models 
Developed at Four Steps in Hierarchic Order 
Global p 
Chi-Square Value 
Step 1. Demographic data: age 9.2 0.002 
Step 2. Demographic and clinical data: age, NYHA 70.1 0.000 
class, 3rd heart sound 
Step 3. Demographic, clinical and echocardiographic 97.4 0.000 
data: age, NYHA class, 3rd heart sound, 
LVEF, left atrial area 
Step 4. Demographic, clinical, echocardiographic 104.7 0.000 
and mitral Doppler data: age, NYHA class, 
3rd heart sound, LVEF, left atrial area, Dec 
time 
Abbreviations a in Table 1. 
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Figure 1. A, Cumulative survival rates considering all-cause mortality 
as an event. B, Cumulative survival rates free of hospital admission for 
congestive heart failure. C, Cumulative survival rates free of all events 
(including death and hospital admission for congestive heart failure) in 
the study cohort of 508 patients with -<35% ejection fraction, accord- 
ing to the value of deceleration time (Dec Time) of early filling. 
graphic, clinical and echocardiographic data further improved 
the chi-square value to 232.5. Survival without congestive heart 
failure and survival without any events according to the value 
of deceleration time are reported in the curves in Figure 1, B 
and C. The cumulative 4-year incidence rate of all hard events 
was 82% in patients with a deceleration time -<125 ms and 
23% in those with a deceleration time >125 ms (p < 0.0001). 
Prognostic data in symptomatic and asymptomatie pa- 
tients. The study group was further analyzed on the basis of 
history of overt heart failure at the time of the entry evaluation. 
At entry, 137 patients had symptomatic left ventricular dys- 
function as defined by a previous unequivocal episode of 
clinical heart failure, and the remaining 371 patients with no 
history of overt heart failure were considered asymptomatic. 
Most symptomatic patients (78%) were in functional class III 
or IV, and all asymptomatic patients were in functional class I
or II. Furthermore, all symptomatic patients were receiving 
digitalis and diuretics; in contrast, only 16% of asymptomatic 
Table 4. Ranked Independent Predictors of Hospital Admission for 
Congestive Heart Failure in Study Cohort by Cox Model According 
to Forward Stepwise Procedure 
p Relative 
Variable Chi-Square Value Risk 95% CI 
Dec time -<125 ms 153.21 0.000 4.88 3.7-6.9 
Overt CHF 46.25 0.000 2.01 1.7-3.1 
NYHA III or IV 11.33 0.001 1.98 1.6-3.0 
Left atrial area >18 cm 2 7.03 0.008 1.69 1.5-2.6 
LVESVI >75 ml/m 2 3.72 0.054 1.42 1.4-2.1 
Each chi-square and p value is a measure of the improvement that each 
selected variable makes in a model containing all other significant variables. The 
relative risk is the independent risk of a cardiac event hat is associated with a 
variable. The total risk is the product of the risks associated with each variable 
when present. Abbreviations a  in Tables 1 and 2. 
patients were taking digitalis, and 46% diuretic drugs (p < 
0.001). Similarly, angiotensin-converting enzyme inhibitors 
were more frequently administered in symptomatic than in 
asymptomatic patients (80% vs. 52%, p < 0.01). Symptomatic, 
compared to asymptomatic, patients also had a greater end- 
diastolic volume (122 _+ 45 vs. 99 + 26 ml/m 2, p < 0.0001) and 
end-systolic volume (95 _+ 38 vs. 70 + 21 ml/m 2, p < 0.0001), 
a lower ejection fraction (24 _+ 7 vs. 29 _+ 5%, p < 0.0001), a
higher E/A ratio (2.5 _+ 1.8 vs. 1.3 _+ 1, p < 0.0001) and a 
shorter deceleration time (120 _+ 42 vs. 154 + 41 ms, p < 
0.0001). The cumulative 4-year event rate was significantly 
higher in symptomatic han in asymptomatic patients (84% vs. 
44%, p < 0.0001). In both groups, deceleration time remained 
the strongest independent predictor of all events (chi-square 
value 21.15 and 58.5, respectively). The proportion of patients 
with a short (-<125 ms) deceleration time was significantly 
higher in symptomatic than in asymptomatic patients (69% vs. 
28%, p < 0.0001). Survival without events according to the 
value of deceleration time is shown in Figure 2. The cumulative 
4-year event rates in symptomatic and asymptomatic patients 
with a deceleration time -<125 ms were 95% and 67%, 
Table 5. Ranked Independent Predictors of All Events (death and 
congestive heart failure) in Study Cohort by Cox Model According 
to Forward Stepwise Procedure 
p Relative 
Variable Chi-Square Value Risk 95% CI 
Dec time -<125 ms 126.25 0.000 2.44 2.0-3.8 
Overt CHF 34.50 0.000 1.63 1.5-2.5 
LVEF -<25% 10.61 0.001 1.52 1.4-2.3 
Left atrial area >18 cm 2 9.25 0.002 1.76 1.5-2.6 
Age >60 yr 4.98 0.026 1.42 1.4-2.1 
Restrictive vs. nonrestrictive 3.36 0.067 2.00 1.8-3.2 
Pulmonary rules 2.81 0.093 1.40 1.4-2.1 
Each chi-square and p value is a measure of the improvement that each 
selected variable makes in a model containing all other significant variables. The 
relative risk is the independent risk of a cardiac event hat is associated with a 
variable. The total risk is the product of the risks associated with each variable 
when present. Abbreviations a  in Tables 1 and 2. 
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Figure 2. Top, Cumulative vent-free survival rates, including all 
events, such as death and hospital admission for congestive heart 
failure, in 137 symptomatic patients with ejection fraction -<35% and 
overt heart failure, according to the value of deceleration time (Dec 
Time) of early filling. Bottom, Cumulative survival rates free of total 
events (death and congestive heart failure) in 371 asymptomatic 
patients with ejection fraction -<35%, according to the value of 
deceleration time of early filling. 
respectively, and the event rates in patients with a deceleration 
time >125 ms were 48% and 18%, respectively (p < 0.001). 
Discuss ion 
Patients with ventricular dysfunction and congestive heart 
failure generally have poor prognosis (1-4,23-26). Although 
there are no univocal data on the prognostic value of the 
various variables that have been considered, some factors, such 
as functional status, left ventricular dimension and function, 
and hemodynamic variables, have emerged as significant and 
useful prognostic indicators (2-4,25,26). Recently, it has be- 
come increasingly apparent that left ventricular diastolic dys- 
function rather than systolic functional impairment may con- 
tribute to signs and symptoms in cardiac patients with various 
underlying diseases who present with congestive heart failure 
(5). However, the long-term prognostic significance of abnor- 
mal left ventricular diastolic filling in patients with systolic 
dysfunction has still to be clearly defined. 
Prognostic value of transmitral Doppler echocardiography. 
The assessment of diastolic function by noninvasive Doppler 
echocardiographic analysis of the transmitral flow has revealed 
a close relation among Doppler parameters of left ventricular 
filling, the severity of clinical symptoms and filling pressure 
(7-12,15). Preliminary data in selected patients have also 
indicated that Doppler-derived diastolic filling variables, in 
particular the restrictive filling pattern, could play an impor- 
tant role in predicting cardiac mortality in patients with dilated 
cardiomyopathy and congestive heart failure (18-21). The 
present study carried out on a large series of patients with 
severe left ventricular systolic dysfunction (with or without 
clinical heart failure) clearly demonstrates that Doppler- 
derived mitral deceleration time of early filling is the most 
powerful independent predictor of future events (all-cause 
mortality and hospitalization for congestive heart failure) 
among demographic, historic, clinical, echocardiographic and 
mitral Doppler variables. In addition, our results indicate that 
patients at higher risk for fatal outcome can be identified by a 
group of noninvasive variables including a short (-<125 ms) 
deceleration time of early filling, advanced functional class, left 
ventricular ejection fraction < 25 %, the presence of third heart 
sound, age >60 years and left atrial area >18 cm 2. All of these 
parameters are independent and additional prognostic indica- 
tors, deceleration time being the single best predictor of 
all-cause mortality. Over a 4-year follow-up period mortality 
occurred in 45% of patients with -<125 ms deceleration time as 
compared with 13% of patients with >125 ms deceleration 
time. 
Comparison with previous tudies. Previous data by Pina- 
monti et al. (19) and Werner et al. (20) indicated the prognos- 
tic value of a short deceleration time of early filling as an index 
of restrictive physiology in small groups of patients with 
idiopathic dilated cardiomyopathy. Other studies found that 
the combination of E/A ratio and deceleration time was a 
better predictor of cardiac mortality than individual Doppler 
echocardiography measurements in patients with cardiac amy- 
loidosis (17), dilated cardiomyopathy and congestive heart 
failure (18,21). For this reason, in the present study we used as 
a definition of restrictive filling pattern by Doppler echocardi- 
ography an E/A ratio ->2 or the combination of an E/A ratio 
between 1 and 2 and a deceleration time -<140 ms (21). The 
"nonrestrictive pattern" was defined as E/A ratio -<1 or E/A 
ratio 1 to 2 with deceleration time >140 ms. Therefore, 
patients who may have had a "pseudonormal" transmitral f ow 
pattern (E/A ratio 1 to 2) were further classified into restrictive 
and nonrestrictive groups on the basis of deceleration time 
measurement. Although at univariate analysis uch a restrictive 
filling pattern was significantly associated with a worse out- 
come, at multivariate analysis it did not prove to be an 
independent predictor of mortality. On the contrary, a short 
(-<125 ms) deceleration time (which was associated with an 
E/A ratio <2 in 38% of patients), irrespective of the filling 
pattern, was found to be the single most powerful indicator of 
poor prognosis. Importantly, when the prognostic value of the 
significant predictors was analyzed in hierarchic order after 
taking account of age, functional class, third heart sound, left 
ventricular ejection fraction and left atrial area, Doppler- 
derived mitral deceleration time of early filling still added 
significant prognostic information. Furthermore, deceleration 
time of early filling remained the most important prognostic 
factor when patients were stratified according to the presence 
or absence of overt heart failure at the time of entry evalua- 
tion: in either symptomatic or asymptomatic patients with left 
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ventricular systolic dysfunction, a short deceleration time 
resulted in the most powerful independent predictor of poor 
prognosis. 
Mechanism. In patients with chronic heart failure, in ad- 
dition to the influence of systolic impairment on survival, a 
relation was also observed between survival and hemodynamic 
indexes of congestion (i.e., increased left ventricular filling 
pressure, pulmonary artery pressure and pulmonary capillary 
wedge pressure) (2,25,26). This could explain the observed 
association between Doppler parameters of diastolic filling, 
particularly deceleration time, and prognosis. Indeed, in pa- 
tients with severe left ventricular systolic dysfunction, we 
recently demonstrated a close negative correlation between 
deceleration time of early filling and pulmonary capillary 
wedge pressure (9,15). As filling pressure increases, the non- 
distensible ventricle may induce a more rapid increase in 
diastolic pressure with a faster equilibration of left atrial and 
left ventricular pressure, resulting in premature cessation of 
mitral flow and a short deceleration time of early filling. In our 
experience, irrespective of the filling pattern as expressed by 
the E/A ratio, a very short deceleration time (-<120 ms) 
reliably predicted a markedly elevated (_>20 mm Hg) pulmo- 
nary wedge pressure, and this was also the case in some 
asymptomatic patients with severe left ventricular dysfunction 
in functional class I or II (15). In line with this observation, the 
results of the present study also demonstrate that a short 
deceleration time, as an expression of a more pronounced 
restrictive physiology and more severe hemodynamic features 
(markedly elevated filling pressure), gives important and in- 
cremental prognostic information in both symptomatic and 
asymptomatic patients. A short deceleration time as an index 
of abnormal filling is clearly superior to the traditional vari- 
ables of left ventricular systolic function (ejection fraction, 
end-systolic volume) in the noninvasive prognostication of 
patients with significant impairment of systolic function. Nota- 
bly, the majority (91%) of patients who died from refractory 
heart failure had a short deceleration time, which was also 
found in a significantly high proportion (65%) of patients who 
had a sudden death (both groups exhibiting similar ejection 
fraction). These data underline the important contribution of 
abnormal filling and diastolic dysfunction i  the clinical dete- 
rioration and prognosis of patients with comparable l ft ven- 
tricular systolic dysfunction. 
Finally, although restrictive filling is a common finding in 
patients with clinical heart failure, a sizable number (28%) of 
asymptomatic patients in our study had a short deceleration 
time (often associated with an apparently normal filling pat- 
tern: E/A ratio <2 in 44% of this subset of patients), indicating 
that a significant hemodynamic impairment may also be 
present in the absence of clinical heart failure, before the 
manifestation fsymptoms. Importantly, our data demonstrate 
that even asymptomatic patients with systolic dysfunction at 
higher risk for adverse outcome may be potentially identified 
by a short deceleration time. 
Study limitations. In the present study, we did not consider 
the pulmonary venous flow velocity pattern, which, as sug- 
gested in a recent report, correlates with left ventricular 
diastolic pressure and may be more accurate than mitral 
Doppler studies in detecting abnormal hemodynamic variables 
(27). We evaluated only the transmitral flow velocity signal 
(obtained with the sample volume placed between the leaflets 
at the point where the highest early flow velocity is recorded) 
because it is more standardized, easy to obtain in all patients 
and extensively used in the noninvasive assessment of left 
ventricular filling abnormalities. However, it should be noted 
that because deceleration time appears to be such a useful 
variable, the sample volume position is critical: different loca- 
tions (too medial, too far into the left ventricle or at the 
annulus) influencing the flow velocity curve could give different 
results. 
Left ventricular filling by mitral Doppler echocardiography 
may be partially affected by several physiologic factors, includ- 
ing age, heart rate, valvular egurgitation and loading condi- 
tions (13,14). In our series of patients, age was an independent 
predictor of prognosis, and no correlation was found between 
age and deceleration time. Tachycardia may increase A wave 
velocity, but it does not seem to influence arly deceleration 
time, which is independent of velocity and heart rate (10,15). 
Similarly, although mitral regurgitation may influence E veloc- 
ity, it was not found to be independently correlated with 
deceleration time and prognosis. Digitalis and diuretics were 
more frequently administered in nonsurvivors (as they were 
more symptomatic) than in survivors, and angiotensin- 
converting enzyme inhibitors and nitrates were equally distrib- 
uted over the two groups. However, at multivariate analysis, 
the use of these drugs was not independently related to 
survival. Therefore, loading conditions and medical treatment 
were not likely to have influenced our results. Finally, the use 
of a single Doppler echocardiographic examination to assess 
prognosis has some limitations because the transmittal f ow 
pattern may change during the follow-up period (20,21). In 
spite of the dynamic nature of diastolic filling, our data indicate 
that patients with left ventricular systolic dysfunction should be 
considered at higher risk for adverse outcome whenever a 
short deceleration time of early filling is documented. Serial 
Doppler echocardiographic follow-up studies are needed to 
provide further insights into the complex diastolic filling dy- 
namics and to investigate whether a reversible restrictive 
physiology (prolongation of an initially short deceleration 
time) with long-term medical therapy may predict (or be 
associated with) a more favorable prognosis. 
Conclusions. Doppler-derived mitral deceleration time of 
early filling is a powerful independent predictor of poor 
prognosis in both symptomatic and asymptomatic patients with 
left ventricular dysfunction. The presence of a short (-< 125 ms) 
deceleration time by mitral Doppler echocardiography as an 
index of abnormal filling and diastolic dysfunction adds impor- 
tant prognostic information compared with other clinical, 
demographic and echocardiographic data (including tradi- 
tional variables of left ventricular systolic function), and it 
identifies patients at very high risk of subsequent death and/or 
hospitalization for congestive heart failure. 
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